Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Using plasma to fight COVID-19

Carolyn Barber, MD
Conditions
July 22, 2020
Share
Tweet
Share

We’ve gotten used to a life of restricted menu options during this pandemic, an analogy that extends all the way to our treatment if we contract COVID-19. But there’s an item still on the list at most medical institutions, and if it strikes you as familiar, it should: It’s been around – and working – for more than a century.

Convalescent plasma therapy, in fact, is promising enough that it’s something you and your doctor may want to consider if you’re sick and hospitalized. It’s got history, it isn’t very risky (more on that in a moment), and, however sadly, the pool of potential plasma donors to fight coronavirus in the U.S. is growing rapidly.

You may not have heard the term “convalescent plasma” in full, but chances are it still rings a bell. That’s the power of celebrity. Tom Hanks, Rita Wilson, and George Stephanopoulos are among the well-known Americans who’ve donated plasma after recovering from COVID-19, and they’ve advocated for other recovered patients to do the same.

Here’s the gist of the concept: Plasma is the yellow portion of the blood that contains antibodies, which we use to fight infection. A person who has already recovered from COVID-19 often has developed such antibodies, according to recent data. Thus, injecting that person’s plasma into an ill individual may help boost the immune system, avert a tragic end, and speed recovery.

It is hardly new. Convalescent plasma has been used to treat bacterial and viral infections going back to diptheria outbreaks in the 1890’s and the Spanish Flu in 1918. In recent decades, the tactic was used to fight H1N1 influenza, SARS, and Ebola outbreaks with some documented success.

With treatment options lacking right now, plasma infusions merit a close look. We’ve had so many people – more than 1.3 million – become infected and then recover in the U.S. that the potential donor base is large. Currently, the treatment is being offered primarily to those who are seriously or critically ill, with more than 31,000 patients receiving the plasma. Multiple studies show that it appears to be a safe therapy.

The historical medical literature is encouraging, from a review of Spanish influenza pneumonia patients decades ago to a trial of 80 patients with SARS in Hong Kong, where those treated with convalescent plasma before day 14 of their infection had almost four times better outcomes – and three times better survival rates – than patients receiving plasma later. Though some of this research is limited by poor design or lack of randomization, it offers some precedent for investigating plasma and its potential efficacy.

Multiple studies have demonstrated that plasma infusions reduce the amount of virus in the blood, although I should point out that not all have shown a mortality benefit, including a recent meta-analysis of severe influenza patients and an Ebola trial. But what about COVID-19, you ask?

The best answer: It’s promising, and it’s early.

The first reported use of convalescent plasma to treat COVID-19, in five critically ill patients in Wuhan, China, resulted in the patients’ clinical status improving, with three of them coming off ventilators and being discharged. In a second Chinese study, all ten patients with severe illness not only improved clinically, but also had higher oxygenation levels and demonstrated positive changes in their lung scans. Recent reports from Italy indicate lower mortality rates with plasma use in COVID-19 patients there. Not all the studies are failsafe, mind you, but these recent returns are good.

A small, non-peer-reviewed study from Mount Sinai Hospital found that 39 severely ill, COVID-19 individuals who received convalescent plasma experienced better outcomes than patients not given the treatment. In fact, preliminary data suggest that nearly half as many patients died in the plasma group as in the control group. Getting the treatment earlier in the disease course appears to be important; the researchers did not find a benefit in more critically ill patients, who already had been placed on ventilators in the ICU. By that point, the horse may have already left the barn, rendering plasma therapy less effective.

At Houston Methodist hospitals, 25 patients with severe or life-threatening cases of COVID-19 were provided plasma, and within two weeks, more than three-quarters of them showed some degree of improvement. And a very recently published randomized control trial of 103 severely ill patients in Wuhan, though it did not reach statistical significance, trended toward better outcomes in the convalescent plasma group versus the standard treatment group.

Convalescent plasma has become a hot commodity. Twenty countries in Europe are using or plan to use it. In the U.S., physicians from 57 institutions established the National COVID-19 Convalescent Plasma Project to better investigate its use to treat the virus.

ADVERTISEMENT

As we surpass 11 million cases and 530,000 deaths worldwide from COVID-19, we face an immediate and unprecedented challenge. With the data limitations noted, I believe the literature gives us hope that plasma treatment can make an immediate difference. In fact, it may be one of our most promising therapy options available right now, along with steroids and proning patients.

Better-designed trials are already underway, looking at plasma’s use both in severe and less severe cases, and as a form of prevention in individuals who are exposed to the virus, like health care workers. In a world of limited options, this oldie could prove golden.

Carolyn Barber is an emergency physician.

Image credit: Shutterstock.com

Prev

Obesity and the diet-microbiome connection: a conversation with a gastroenterologist [PODCAST]

July 21, 2020 Kevin 0
…
Next

Writing tips for physicians from a health care editor

July 22, 2020 Kevin 1
…

Tagged as: COVID, Infectious Disease

Post navigation

< Previous Post
Obesity and the diet-microbiome connection: a conversation with a gastroenterologist [PODCAST]
Next Post >
Writing tips for physicians from a health care editor

ADVERTISEMENT

Related Posts

  • How to get patients vaccinated against COVID-19 [PODCAST]

    The Podcast by KevinMD
  • COVID-19 divides and conquers

    Michele Luckenbaugh
  • State sanctioned executions in the age of COVID-19

    Kasey Johnson, DO
  • A patient’s COVID-19 reflections

    Michele Luckenbaugh
  • Starting medical school in the midst of COVID-19

    Horacio Romero Castillo
  • COVID-19 shows why we need health insurance

    Jingyi Liu, MD

More in Conditions

  • How President Biden’s cognitive health shapes political and legal trust

    Muhamad Aly Rifai, MD
  • The emotional first responders of aesthetic medicine

    Sarah White, APRN
  • Why testosterone matters more than you think in women’s health

    Andrea Caamano, MD
  • How veteran health care is being transformed by tech and teamwork

    Deborah Lafer Scher
  • What Elon Musk and Diddy reveal about the price of power

    Osmund Agbo, MD
  • Understanding depression beyond biology: the power of therapy and meaning

    Maire Daugharty, MD
  • Most Popular

  • Past Week

    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
    • How New Mexico became a malpractice lawsuit hotspot

      Patrick Hudson, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
  • Past 6 Months

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
    • Why Medicaid cuts should alarm every doctor

      Ilan Shapiro, MD | Policy
  • Recent Posts

    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Decoding your medical bill: What those charges really mean

      Cheryl Spang | Finance
    • The emotional first responders of aesthetic medicine

      Sarah White, APRN | Conditions
    • Why testosterone matters more than you think in women’s health

      Andrea Caamano, MD | Conditions
    • A mind to guide the machine: Why physicians must help shape artificial intelligence in medicine

      Shanice Spence-Miller, MD | Tech
    • How subjective likability practices undermine Canada’s health workforce recruitment and retention

      Olumuyiwa Bamgbade, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
    • How New Mexico became a malpractice lawsuit hotspot

      Patrick Hudson, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
  • Past 6 Months

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
    • Why Medicaid cuts should alarm every doctor

      Ilan Shapiro, MD | Policy
  • Recent Posts

    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Decoding your medical bill: What those charges really mean

      Cheryl Spang | Finance
    • The emotional first responders of aesthetic medicine

      Sarah White, APRN | Conditions
    • Why testosterone matters more than you think in women’s health

      Andrea Caamano, MD | Conditions
    • A mind to guide the machine: Why physicians must help shape artificial intelligence in medicine

      Shanice Spence-Miller, MD | Tech
    • How subjective likability practices undermine Canada’s health workforce recruitment and retention

      Olumuyiwa Bamgbade, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...